Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
8.81
-0.02 (-0.23%)
Apr 29, 2026, 3:27 PM EDT - Market open
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $782.00 million as of April 29, 2026. Its market cap has increased by 67.81% in one year.
Market Cap
782.00M
Enterprise Value
132.55M
1-Year Change
67.81%
Ranking
Category
Stock Price
$8.81
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $782.00M, an increase of 587.77%. That is a compound annual growth rate of 20.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 780.00M | -13.73% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 817.30M |
| Crescent Biopharma | 796.17M |
| Design Therapeutics | 790.02M |
| ARS Pharmaceuticals | 788.42M |
| Vor Biopharma | 779.19M |
| Cullinan Therapeutics | 775.34M |
| SpyGlass Pharma | 762.29M |
| Relmada Therapeutics | 759.39M |